Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol versus tiotropium in COPD over 52 weeks
2008-007944-33Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Indacaterol arm with Tiotropium arm (2 arms). Primary endpoint: Trough FEV1 at 12 weeks. Started Jan 2009; status: completed.
02
Drugs
indacateroltiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-007944-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007944-33.